Clinical Trials

NCT03924895 | ACTIVE_NOT_RECRUITING | PHASE3
595 participants
NCT03241940 | ACTIVE_NOT_RECRUITING | PHASE1
33 participants

Study of CD19/CD22 Chimeric Antigen Receptor T Cells in Children & Young Adults w/ Recurrent or Refractory B Cell Malignancies

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-30
Start Date:
2017-10-20
Completion:
2025-04-03
Conditions
  • B Acute Lymphoblastic Leukemia
  • CD19 Positive
  • Minimal Residual Disease
  • Philadelphia Chromosome Positive
  • Recurrent Adult Acute Lymphoblastic Leukemia
  • Recurrent Childhood Acute Lymphoblastic Leukemia
  • Refractory Acute Lymphoblastic Leukemia
Interventions
  • BIOLOGICAL
  • DRUG
  • OTHER
No Results Yet
NCT03012100 | ACTIVE_NOT_RECRUITING | PHASE2
280 participants

Multi-epitope Folate Receptor Alpha Peptide Vaccine, GM-CSF, and Cyclophosphamide in Treating Patients With Triple Negative Breast Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-30
Start Date:
2017-03-31
Completion:
2025-02-28
Conditions
  • Bilateral Breast Carcinoma
  • Breast Inflammatory Carcinoma
  • Stage IB Breast Cancer AJCC v7
  • Stage II Breast Cancer AJCC v6 and v7
  • Stage IIA Breast Cancer AJCC v6 and v7
  • Stage IIB Breast Cancer AJCC v6 and v7
  • Stage III Breast Cancer AJCC v7
  • Stage IIIA Breast Cancer AJCC v7
  • Stage IIIB Breast Cancer AJCC v7
  • Stage IIIC Breast Cancer AJCC v7
  • Triple-Negative Breast Carcinoma
  • Unilateral Breast Carcinoma
Interventions
  • BIOLOGICAL
  • OTHER
  • DRUG
Previous
Sorted by latest updates
Next
Showing 40 trials per page